169 related articles for article (PubMed ID: 9301278)
1. [Blood components: indication and notice of transfusion].
Sekiguchi S
Nihon Rinsho; 1997 Sep; 55(9):2205-13. PubMed ID: 9301278
[TBL] [Abstract][Full Text] [Related]
2. [Labile blood products and their preparation].
Chabanel A; Folléa G
Rev Prat; 2001 Jun; 51(12):1306-10. PubMed ID: 11503503
[TBL] [Abstract][Full Text] [Related]
3. The effect of double- and triple-apheresis platelet product donation on apheresis donor platelet and white blood cell counts.
Richa E; Krueger P; Burgstaler EA; Bryant SC; Winters JL
Transfusion; 2008 Jul; 48(7):1325-32. PubMed ID: 18346017
[TBL] [Abstract][Full Text] [Related]
4. Quality analysis of blood components obtained by automated buffy-coat layer removal with a top & bottom system (Optipress (R)II).
Hurtado C; Bonanad S; Soler Mf; Mirabet V; Blasco I; Planelles Mf; De Miguel A
Haematologica; 2000 Apr; 85(4):390-5. PubMed ID: 10756365
[TBL] [Abstract][Full Text] [Related]
5. [Report on notifications pursuant to Section 21 German Transfusion Act for 2007].
Henseler O; Heiden M; Haschberger B; Hesse J; Seitz R
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2009 Jul; 52(7):715-31. PubMed ID: 19572110
[TBL] [Abstract][Full Text] [Related]
6. Blood collection and transfusion in the United States in 2001.
Sullivan MT; Cotten R; Read EJ; Wallace EL
Transfusion; 2007 Mar; 47(3):385-94. PubMed ID: 17319817
[TBL] [Abstract][Full Text] [Related]
7. Universal leukodepletion of blood components results in a significant reduction of febrile non-hemolytic but not allergic transfusion reactions.
Pruss A; Kalus U; Radtke H; Koscielny J; Baumann-Baretti B; Balzer D; Dörner T; Salama A; Kiesewetter H
Transfus Apher Sci; 2004 Feb; 30(1):41-6. PubMed ID: 14746820
[TBL] [Abstract][Full Text] [Related]
8. Standardization of the red cell product.
Sweeney JD
Transfus Apher Sci; 2006 Apr; 34(2):213-8. PubMed ID: 16510312
[TBL] [Abstract][Full Text] [Related]
9. Blood collection and transfusion in the United States in 1999.
Sullivan MT; Wallace EL
Transfusion; 2005 Feb; 45(2):141-8. PubMed ID: 15660821
[TBL] [Abstract][Full Text] [Related]
10. [Analysis of the quality of hemoderivatives obtained using a buffy-coat extraction system with a top-and-bottom technique (Optipress II)].
Hurtado C; Bonanad S; Soler MA; Mirabet V; Blasco I; Planelles MD; de Miguel A
Sangre (Barc); 1999 Oct; 44(5):319-26. PubMed ID: 10618907
[TBL] [Abstract][Full Text] [Related]
11. Pooled platelet concentrates: an alternative to single donor apheresis platelets?
Pietersz RN
Transfus Apher Sci; 2009 Oct; 41(2):115-9. PubMed ID: 19716340
[TBL] [Abstract][Full Text] [Related]
12. [Report on Notifications pursuant to Section 21 German Transfusion Act for 2001 and 2002].
Haschberger B; Waterkamp A; Heiden M; Seitz R
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2005 Jan; 48(1):99-119. PubMed ID: 15650911
[TBL] [Abstract][Full Text] [Related]
13. [Blood transfusion therapy at the Military Medicine Academy--present possibilities].
Taseski J; Balint B; Radović M
Vojnosanit Pregl; 2000; 57(5):17-27. PubMed ID: 11213671
[TBL] [Abstract][Full Text] [Related]
14. Implementation of a strategy to prevent TRALI in a regional blood centre.
Insunza A; Romon I; Gonzalez-Ponte ML; Hoyos A; Pastor JM; Iriondo A; Hermosa V
Transfus Med; 2004 Apr; 14(2):157-64. PubMed ID: 15113380
[TBL] [Abstract][Full Text] [Related]
15. Preparation of blood products for transfusion: is there a best method?
Devine DV; Serrano K
Biologicals; 2012 May; 40(3):187-90. PubMed ID: 22119012
[TBL] [Abstract][Full Text] [Related]
16. [Report on notifications pursuant to Section 21 of the German Transfusion Act for the years 2008 and 2009].
Henseler O; Heiden M; Haschberger B; Hesse J; Seitz R
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2010 Oct; 53(10):1089-103. PubMed ID: 20936454
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of Cobe Trima for the collection of blood components with particular reference to the in vitro characteristics of the red cell and platelet concentrates and the clinical responses to transfusion.
Murphy MF; Seghatchian J; Krailadsiri P; Howell C; Verjee S
Transfus Sci; 2000; 22(1-2):39-43. PubMed ID: 10771377
[TBL] [Abstract][Full Text] [Related]
18. Platelet concentrates from buffy coats: improved conditions for preparation and evaluation in routine clinical use.
Rebulla P; Bertolini F; Porretti L; Marangoni F; Smacchia C; Marconi M; Riccardi D; Sirelson V; Pappalettera M; Sirchia G
Transfus Sci; 1993 Jan; 14(1):41-6. PubMed ID: 10148312
[TBL] [Abstract][Full Text] [Related]
19. [Advancement in the preparation of red cell concentrates and platelet concentrates].
Inaba S
Masui; 2011 Jan; 60(1):23-30. PubMed ID: 21348247
[TBL] [Abstract][Full Text] [Related]
20. A program to limit donor exposures to neonates undergoing extracorporeal membrane oxygenation.
Rosenberg EM; Chambers LA; Gunter JM; Good JA
Pediatrics; 1994 Sep; 94(3):341-6. PubMed ID: 8065860
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
